Nebenwirkungen · Conexxence
Conexxence 60 mg solution for injection in pre-filled syringe · Abschnitt 4.8 · PDF-Seite 6–7
HOS-152339 · Präparat HOS-100733
The following convention has been used for the classification of the adverse reactions (see table 1): very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1 000 to < 1/100), rare (≥ 1/10 000 to < 1/1 000), very rare (< 1/10 000) and not known (cannot be estimated from the available data). Within each frequency grouping and system organ class, adverse reactions are presented in order of decreasing seriousness. Table 1. Adverse reactions reported in patients with osteoporosis and breast or prostate cancer patients receiving hormone ablation
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-18T23:00:00Z · SHA-256 3b88e805c7567f6fffd8772623b663b6b876e38ae5fddfae90c285733d588e23 · Passage bea0630d7b37e8ed685ba9b95fe85384ee340cb8ffce5132ba475851dad29128 · Zeichen 685–1251 im Abschnitt